3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Leukemia
10
Burkitt Lymphoma
9
Recurrence
8
Lymphoproliferative Disorders
6
Lymphoma, Non-Hodgkin
5
Lymphatic Diseases
5
Immunoproliferative Disorders
4
Neoplasms
3
Neoplasm, Residual
3
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma
2
Leukemia, Lymphoid
2
Neoplasms by Histologic Type
1
Myelodysplastic Syndromes
1
Lymphoma, B-Cell
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Large Granular Lymphocytic
1
Leukemia, Biphenotypic, Acute
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Bites and Stings
1
Interventions
Tacrolimus
29
fludarabine phosphate
21
Methotrexate
21
Cyclophosphamide
21
Mycophenolic Acid
18
Busulfan
15
Antilymphocyte Serum
14
Whole-Body Irradiation
13
Sirolimus
12
fludarabine
11
Peripheral Blood Stem Cell Transplantation
11
Cyclosporine
9
thymoglobulin
8
Melphalan
8
Hematopoietic Stem Cell Transplantation
6
Granulocyte Colony-Stimulating Factor
6
Filgrastim
6
Rituximab
5
Pentostatin
5
Methylprednisolone
5
Thiotepa
4
Stem Cell Transplantation
4
Radiotherapy
4
Cyclosporins
4
ruxolitinib
3
Vorinostat
3
Transplantation
3
Flow Cytometry
3
Etoposide
3
merphos
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Graft vs Host Disease
×
blinatumomab
×
Clear all
No trials found.